Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification

Publication date: 28 October 2021Source: Journal of Ethnopharmacology, Volume 279Author(s): Yan Wang, Fuhao Chu, Jie Lin, Yuan Li, Nadia Johnson, Jianglan Zhang, Cong Gai, Zeqi Su, Hongjie Cheng, Linheng Wang, Xia Ding
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research